Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pneumatocoeles after bronchoscopic lung volume reduction with valves.
Lestelle F, Fumat R, Didier A, Collot S, Egenod T, Faviez G, Hermant C, Plat G, Guibert N. Lestelle F, et al. Among authors: faviez g. ERJ Open Res. 2021 Apr 6;7(2):00747-2020. doi: 10.1183/23120541.00747-2020. eCollection 2021 Apr. ERJ Open Res. 2021. PMID: 33834053 Free PMC article.
Severe SARS-CoV-2 pneumonia: Clinical, functional and imaging outcomes at 4 months.
Noel-Savina E, Viatgé T, Faviez G, Lepage B, Mhanna LT, Pontier S, Dupuis M, Collot S, Thomas P, Idoate Lacasia J, Crognier L, Bouharaoua S, Silva Sifontes S, Mazieres J, Prévot G, Didier A. Noel-Savina E, et al. Among authors: faviez g. Respir Med Res. 2021 Nov;80:100822. doi: 10.1016/j.resmer.2021.100822. Epub 2021 Apr 28. Respir Med Res. 2021. PMID: 34242974 Free PMC article.
[Parsonage-Turner syndrome following severe SARS-CoV-2 infection].
Viatgé T, Noel-Savina E, Prévot G, Faviez G, Plat G, De Boissezon X, Cintas P, Didier A. Viatgé T, et al. Among authors: faviez g. Rev Mal Respir. 2021 Oct;38(8):853-858. doi: 10.1016/j.rmr.2021.06.004. Epub 2021 Jun 26. Rev Mal Respir. 2021. PMID: 34325956 Free PMC article. French.
Rapid Improvement after Starting Elexacaftor-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease.
Burgel PR, Durieu I, Chiron R, Ramel S, Danner-Boucher I, Prevotat A, Grenet D, Marguet C, Reynaud-Gaubert M, Macey J, Mely L, Fanton A, Quetant S, Lemonnier L, Paillasseur JL, Da Silva J, Martin C; French Cystic Fibrosis Reference Network Study Group. Burgel PR, et al. Am J Respir Crit Care Med. 2021 Jul 1;204(1):64-73. doi: 10.1164/rccm.202011-4153OC. Am J Respir Crit Care Med. 2021. PMID: 33600738
[Epidemiology of fibrosing interstitial lung diseases in the department of Haute Garonne].
Villeneuve T, Prévot G, Lintz F, Mourin G, Ferry G, Bousquet E, Perelroizen H, Boghanim T, Faviez G, Noël-Savina E, Collot S, Le Borgne A, Didier A. Villeneuve T, et al. Among authors: faviez g. Rev Mal Respir. 2021 Dec;38(10):972-979. doi: 10.1016/j.rmr.2021.07.004. Epub 2021 Oct 8. Rev Mal Respir. 2021. PMID: 34629221 French.
Multisystemic Effects of Elexacaftor-Tezacaftor-Ivacaftor in Adults with Cystic Fibrosis and Advanced Lung Disease.
Burgel PR, Paillasseur JL, Durieu I, Reynaud-Gaubert M, Hamidfar R, Murris-Espin M, Danner-Boucher I, Chiron R, Leroy S, Douvry B, Grenet D, Mely L, Ramel S, Montcouquiol S, Burnet E, Ouaalaya EH, Sogni P, Da Silva J, Martin C; Participating Investigators of the French Cystic Fibrosis Reference Network Study Group. Burgel PR, et al. Ann Am Thorac Soc. 2024 Jul;21(7):1053-1064. doi: 10.1513/AnnalsATS.202312-1065OC. Ann Am Thorac Soc. 2024. PMID: 38579175